Roselabs Finance Ltd
Roselabs Finance Ltd (ROSELABS): company summary
The company's annual revenue rose 70.4% to ₹1 crore, but annual net profit remained at a loss of ₹0 crore.
Roselabs Finance Ltd (ROSELABS) is a micro-cap Financial Services company valued at ₹21 crore operating in Other Financial Services on the NSE and BSE.
- Recent price move
- Roselabs Finance Ltd last traded at ₹20.88, up 4.92% on the day.
- Recent developments
- On 2026-09-30, the promoter holding was reported at 74.25%, with no changes noted in foreign or domestic institutional holdings. The company reported a net loss of ₹0 crore in its latest financial year ending 2026-03-31, consistent with previous quarters.
- Financial performance
- The company's annual revenue rose 70.4% to ₹1 crore, but annual net profit remained at a loss of ₹0 crore. The latest quarter showed no revenue or profit, with the loss widening from ₹0 crore to ₹0 crore compared to the same quarter a year earlier. The net profit margin improved from -41.1% to -25.4%, but return on capital employed remained at -500.0%.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at -4.60 times book value.
- Things to watch
- The company has reported a net loss of ₹0 crore for the latest financial year, with no revenue or profit in the latest quarter. The return on capital employed is at -500.0%, indicating significant financial strain. The stock is 29.5% below its 52-week high.
- Where it stands
- The company remains in a loss position with no revenue or profit in the latest quarter. The net loss remained at ₹0 crore, and the stock is 29.5% below its 52-week high. The return on capital employed is at -500.0%, highlighting ongoing financial challenges.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (7.5), but held back by quality (0.1). Growth looks strong at 7.5, but that is offset by quality at 0.1 and momentum at 3.0. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.
DocStoX score
Low confidenceScored on 4 of 5 measures — the rest have no data for this company.
At a glance
Key highlights
- Revenue compounding 50% a year
- Loss-making — no meaningful P/E
- Loss-making in some of the last 5 years
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Financial Services stocks · Other Financial Services
Explore Roselabs Finance Ltd’s valuation
Free deep-dive tools · no sign-up
Roselabs Finance Ltd peers in Financial Services
Other Financial Services stocks on the NSE & BSE. See the full Financial Services sector list.
Related tools & concepts
Value Roselabs Finance Ltd with the ratios and calculators DocStoX uses in its analysis.

